Role of the Phosphatidylinositol 3′-Kinase-Akt Signal Pathway in the Proliferation of Human Pancreatic Ductal Carcinoma Cell Lines

Pancreas

Volumn 28, Issue 3, 2004, Pages 353-358

  Takeda, Ami ^a   Osaki, Mitsuhiko ^a,b   Adachi, Keiko ^a   Honjo, Soichiro ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Cell cycle arrest; LY294002; P27 Kip1; Pancreatic ductal carcinoma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLIN E; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P27; PROTEIN PPRB; PROTIEN CDK4; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN KP 4; CELL STRAIN PANC 1; CELL STRAIN PSN 1; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREATIC DUCTAL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CHROMONES; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; MORPHOLINES; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 1842430485     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200404000-00026     Document Type: Article

References (34)

1. Foundation for Promotion of Cancer Research. Cancer Statistics in Japan 2001. Tokyo, 2001
2. Poston GJ, Gillespie J, Guillou PJ. Biology of pancreatic cancer. Gut. 1991;2:800-812.
3. Warshaw AL, Castillo CF. Pancreatic carcinoma. N Engl J Med. 1992; 326:455-465.
4. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;12:897-909.
5. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras gene. Cell. 1998;53:549-554.
6. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br J Cancer. 1991; 64:1076-1082.
7. Lefter LP, Furukawa T, Sunamura M, et al. Suppression of the tumorigeni phenotype by chromosome 18 transfer into pancreatic cancer cell lines. Genes Chromosomes Cancer. 2002;27:234-242.
8. Perugini RA, McDade TP, Vittimberga FJ, et al. The molecular and cellular biology of pancreatic cancer. Crit Rev Eukaryot Gene Expr. 1998;8: 377-393.
9. Schleger C, Arens N, Zentgraf H, et al. Identification of frequent chromosome aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J Pathol. 2000;191:27-32.
10. Bruce AR, Lingyi H, Berger D, et al. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesion. Cancer. 1997;79:700-716.
11. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell. 1997;88:435-437.
12. Boudewiji MT, Coffer PJ. Protein kinaseB (c-Akt) in phosphatidylinositol -3-OH kinase signal transduction. Nature. 1995;376:599-602.
13. Franke TF, Yang S, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995;81:727-736.
14. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231-241.
15. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318-1321.
16. Semba S, Moriya T, Kimura W, et al. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas. Pancreas. 2003;26:250-257.
17. 1. Cancer Res. 1999; 59:1449-1453.
18. Del Bufalo D, Di Castro V, Biroccio A, et al. Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation. Mol Pharmacol. 2002;61:524-532.
19. Duforny B, Alblas J, Teeffelen HA, et al. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem. 1997;272:31163-31171.
20. Seufferlein T, Rozengurt E. Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Cancer Res. 1996;56:3895-3897.
21. Kohn AD, Takeuchi F, Roth RA. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem. 1996;271:21920-21926.
22. Hemming BA. PtdIns (3,4,5) P3 gets its message across. Science. 1997; 277:534.
23. Vlahos CJ, Matter WF, Hui KY, et al. A apecific 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994;269: 5241-5248.
24. Hayashi H, Tatebe S, Osaki M, et al. Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines. Jpn J Cancer Res. 1997;88:49-55.
25. Bondar VM, Sweeney-Gotsch B, Andreeff M, et al. Inhibition of the phosphatidylinositol 3′-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther. 2002;1:989-997.
26. Pestell RG, Albanese C, Reutens AT, et al. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrine. 1999;20:501-534.
27. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1 phase progression. Genes Dev. 1999;13:1501-1512.
28. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med. 2002;8:1136-1144.
29. Hengst L, Reed SI. Translational control of p27/Kip1 accumulation during the cell cycle. Science. 1996;271:1861-1864.
30. Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995;269:682-685.
31. Xu K, Belunis C, Chu W, et al. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase. Biochem J. 2003;371:957-964.
32. Bloom J, Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Cancer Biol. 2003;13:41-47.
33. Fujita N, Sata N, Katayama K, et al. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem. 2002;277:28706-28713.
34. KIP1. Biochem Biophys Res Commun. 1998;244:630-636.